2003
DOI: 10.1038/sj.onc.1206733
|View full text |Cite
|
Sign up to set email alerts
|

Use of adeno-associated viral vector for delivery of small interfering RNA

Abstract: Post-transcriptional gene silencing by small interfering RNAs (siRNAs) is rapidly becoming a powerful tool for genetic analysis of mammalian cells. Delivery of siRNA into mammalian cells is usually achieved via the transfection of double-stranded oligonucleotides or plasmids encoding RNA polymerase III promoter-driven small hairpin RNA. Recently, retroviral vectors have been used for siRNA delivery, which overcome the problem of poor transfection efficiency seen with the plasmid-based systems. However, retrovi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
91
0
1

Year Published

2004
2004
2020
2020

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 181 publications
(92 citation statements)
references
References 19 publications
0
91
0
1
Order By: Relevance
“…Retroviral, 50 adenoviral, 51 adeno-associated viral 52 and lentiviral 40 vectors engineered to express siRNA have been proposed, taking advantage of high rate transfection in vivo into tumor cells. 36,39 Moreover, viral vectors may enable relatively persistent RNAi effect in comparison with transient gene silencing obtained by synthetic siRNA duplexes.…”
Section: Discussionmentioning
confidence: 99%
“…Retroviral, 50 adenoviral, 51 adeno-associated viral 52 and lentiviral 40 vectors engineered to express siRNA have been proposed, taking advantage of high rate transfection in vivo into tumor cells. 36,39 Moreover, viral vectors may enable relatively persistent RNAi effect in comparison with transient gene silencing obtained by synthetic siRNA duplexes.…”
Section: Discussionmentioning
confidence: 99%
“…To generate pSUPER-Casp2/ EGFP, the pSUPER/EGFP was digested with BglII and HindIII, and the annealed targeting oligonucleotides ACAGCTGTTGTTGAGCGAA (14) were ligated into the vector. To generate pSUPER-Casp3/EGFP and pSUPER-Casp8/EGFP, the pSUPER/EGFP was digested with BglII and HindIII, and the annealed targeting oligonucleotides TGA-CATCTCGGTCTGGTAC (29) and GTTCCTGAGCCTGGACTAC (30) were ligated into the vector, respectively. The pSUPER-Casp2 (-3 or -8)/EGFP/Neo was generated by inserting the Neo r gene from the pIRESneo2 (Clontech) into the pSUPER-Casp2 (-3 or -8)/EGFP vector.…”
Section: Methodsmentioning
confidence: 99%
“…One important feature of AAV2 is that this vector remains confined to the injection site and specifically infects neurons rather than glia (Bartlett et al 1998, Tomar et al 2003, Grimm et al 2005. By inserting an additional expression cassette to encode EGFP for fluorescent detection, we were able to visualize the injection site and AAV transduction in the brain.…”
Section: Discussionmentioning
confidence: 99%